This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

China warns Netherlands over Nexperia dispute, blames Dutch govt for chip disruption

( November 4, 2025, 07:03 GMT | Official Statement) -- MLex Summary: China has vowed to defend the company's lawful rights and urged the Netherlands to stop interfering in the internal affairs of China-owned semiconductor maker Nexperia and to work with Beijing to resolve the dispute, the Commerce Ministry said in a statement Tuesday. The ministry accused the Dutch government of ignoring China’s “reasonable requests” during consultations and of halting wafer supplies from Nexperia Netherlands to its Chinese unit, which it said disrupted production and caused turmoil in the global semiconductor supply chain. Beijing said that, in a bid to stabilize the industry, it granted conditional export exemptions over the weekend to help Nexperia China resume shipments. But the Dutch side has “continued to act unilaterally” without taking practical steps to fix the problem, the ministry said.The statement follows:...

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections